Literature DB >> 23204479

Modeling ETV6-JAK2-induced leukemia: insights from the zebrafish.

Jurg Schwaller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23204479      PMCID: PMC3590083          DOI: 10.3324/haematol.2012.080754

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  26 in total

1.  Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors.

Authors:  Antonio Cozzio; Emmanuelle Passegué; Paul M Ayton; Holger Karsunky; Michael L Cleary; Irving L Weissman
Journal:  Genes Dev       Date:  2003-12-15       Impact factor: 11.361

2.  Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia.

Authors:  P Peeters; S D Raynaud; J Cools; I Wlodarska; J Grosgeorge; P Philip; F Monpoux; L Van Rompaey; M Baens; H Van den Berghe; P Marynen
Journal:  Blood       Date:  1997-10-01       Impact factor: 22.113

3.  Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.

Authors:  V Lacronique; A Boureux; R Monni; S Dumon; M Mauchauffé; P Mayeux; F Gouilleux; R Berger; S Gisselbrecht; J Ghysdael; O A Bernard
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

4.  Alternative TEL-JAK2 fusions associated with T-cell acute lymphoblastic leukemia and atypical chronic myelogenous leukemia dissected in zebrafish.

Authors:  Sara M N Onnebo; Parisa Rasighaemi; Janani Kumar; Clifford Liongue; Alister C Ward
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

5.  Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling.

Authors:  J M Ho; B K Beattie; J A Squire; D A Frank; D L Barber
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

6.  The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.

Authors:  Andreas Reiter; Christoph Walz; Ann Watmore; Claudia Schoch; Ilona Blau; Brigitte Schlegelberger; Ute Berger; Nick Telford; Shilani Aruliah; John A Yin; Danny Vanstraelen; Helen F Barker; Peter C Taylor; Aisling O'Driscoll; Fabio Benedetti; Cornelia Rudolph; Hans-Jochem Kolb; Andreas Hochhaus; Rüdiger Hehlmann; Andrew Chase; Nicholas C P Cross
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

7.  Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes.

Authors:  J Schwaller; J Frantsve; J Aster; I R Williams; M H Tomasson; T S Ross; P Peeters; L Van Rompaey; R A Van Etten; R Ilaria; P Marynen; D G Gilliland
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

8.  Hematopoietic perturbation in zebrafish expressing a tel-jak2a fusion.

Authors:  Sara M N Onnebo; Melanie M Condron; Dora O McPhee; Graham J Lieschke; Alister C Ward
Journal:  Exp Hematol       Date:  2005-02       Impact factor: 3.084

9.  MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.

Authors:  Brian J P Huntly; Hirokazu Shigematsu; Kenji Deguchi; Benjamin H Lee; Shinichi Mizuno; Nicky Duclos; Rebecca Rowan; Sonia Amaral; David Curley; Ifor R Williams; Koichi Akashi; D Gary Gilliland
Journal:  Cancer Cell       Date:  2004-12       Impact factor: 31.743

10.  A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia.

Authors:  V Lacronique; A Boureux; V D Valle; H Poirel; C T Quang; M Mauchauffé; C Berthou; M Lessard; R Berger; J Ghysdael; O A Bernard
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

View more
  2 in total

1.  PCM1::JAK2 fusion associates with an atypical form of mycosis fungoides.

Authors:  Juan Jose Rodriguez-Sevilla; Marta Salido; Maria Rodriguez-Rivera; Blanca Sanchez-Gonzalez; Fernando Gallardo; Ramon Maria Pujol; Luis Colomo
Journal:  Virchows Arch       Date:  2022-07-04       Impact factor: 4.064

2.  New translocation in acute myeloid leukemia M4 eos.

Authors:  Gholamreza Bahoush; Maryam Vafapour; Roxana Kariminejad
Journal:  Leuk Res Rep       Date:  2020-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.